Literature DB >> 15010426

Simple technique for internal control of real-time amplification assays.

Siegfried Burggraf1, Bernhard Olgemöller.   

Abstract

BACKGROUND: In real-time PCR assays, the most accurate way to identify false-negative results, e.g., those caused by PCR inhibitors, is to add to samples an internal control that will be coamplified with the target (e.g., pathogen) DNA. Current internal control procedures, however, which usually involve the introduction of a DNA fragment, are complex, time-consuming, and expensive.
METHODS: Single-stranded oligonucleotides, which contain little more than primer and probe binding sites, were used as internal controls in real-time PCR assays. Mismatches were included in the probe-binding region of the internal control oligonucleotide (ICO) to prevent probe-control hybridization during the fluorescence acquisition step of the PCR. Amplified ICOs were detected by melting point analysis. ICOs could be added directly to the sample material before DNA extraction.
RESULTS: To demonstrate the feasibility of the new approach, we designed ICOs for the LightCycler hybridization probe assays for Mycobacterium tuberculosis complex, hepatitis B virus, herpes simplex virus, and varicella zoster virus. In each case, the controls did not interfere with detection of the pathogen, but were clearly detectable during a subsequent melting point analysis.
CONCLUSIONS: A single-stranded oligonucleotide that mimics the target region of the pathogen but is clearly distinguishable from the target during melting point analysis can serve as a simple, cost-effective internal control for real-time amplification assays. Such control oligonucleotides are easy to design and inexpensive. A costly second probe system is not necessary. Moreover, the internally controlled assay uses only one fluorescence detection channel of the instrument, leaving the second channel free for multiplex applications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15010426     DOI: 10.1373/clinchem.2003.027961

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

Review 1.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  Effect of rSAG-1(P30) immunisation on the circulating and tissue parasites in guinea pigs as determined by quantitative PCR.

Authors:  Pierre Flori; Laëtitia Tardy; Alain Jacquet; Bahrie Bellete; Jamal Hafid; Hélène Raberin; Roger Tran Manh Sung
Journal:  Parasitol Res       Date:  2006-01-17       Impact factor: 2.289

3.  Comparison of an internally controlled, large-volume LightCycler assay for detection of Mycobacterium tuberculosis in clinical samples with the COBAS AMPLICOR assay.

Authors:  Siegfried Burggraf; Udo Reischl; Naeem Malik; Markus Bollwein; Ludmila Naumann; Bernhard Olgemöller
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Comparison of real-time polymerase chain reaction with the COBAS Amplicor test for quantitation of hepatitis B virus DNA in serum samples.

Authors:  Ming Shi; Yong Zhang; Ying-Hua Zhu; Jing Zhang; Wei-Jia Xu
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

5.  Comparison of Abbott and Da-an real-time PCR for quantitating serum HBV DNA.

Authors:  Ning Qiu; Rui Li; Jian-Guo Yu; Wen Yang; Wei Zhang; Yong An; Tong Li; Xue-En Liu; Hui Zhuang
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

6.  Designing novel and simple competitive internal amplification control for reliable PCR diagnosis of herpes simplex virus.

Authors:  Asiye Akbarian; Mohammad Hassan Shahhosseiny; Somayeh Vafaei; Elham Moslemi; Maryam Ghahri
Journal:  Jundishapur J Microbiol       Date:  2015-02-20       Impact factor: 0.747

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.